McAndrews Secures Second Victory for Client Accord Healthcare, Inc.
09.12.24
On Sept. 9, 2024, Judge Bryson of the Court of Appeals for the Federal Circuit, sitting by designation for the District Court for the District of Delaware, issued an opinion in favor of McAndrews client Accord Healthcare, Inc.
For the second time in as many years, the McAndrews ANDA litigation team successfully defended its client, Accord, against claims of patent infringement by Purdue Pharma. Accord filed an abbreviated new drug application for approval to market a generic version of Purdue Pharma’s OxyContin® branded extended release oxycodone hydrochloride tablets. In April 2023, Judge Andrews agreed with Accord that the five patents asserted by Purdue were invalid. In the current case, Judge Bryson agreed with Accord and invalidated yet another Purdue patent.
Accord is represented by Alex Menchaca, Raj Chiplunkar, Ben Mahon, and Brad Loren.